Close Menu

Burnham Institute

Following a $50 million pledge of support from T. Denny Sanford, the institute has been renamed the Sanford-Burnham Medical Research Institute.

After a delay due to California's budget difficulties, the Sanford Consortium for Regenerative Medicine has broken ground on a $126 million research facility intended to foster collaborations in the San Diego area.

The Burnham Institute's endowment declined 13 percent, due primarily to losses on investments, but its assets nearly doubled on grants from the State of Florida.

The institute recently hired two senior managers as it focuses greater attention on its drug commercialization and partnering efforts.

The collaboration will combine mass spec-based metabolite profiling expertise at Duke's Sarah W. Stedman Nutrition and Metabolism Center with complementary technologies at Burnham, particularly NMR-based methods.

The phosphoproteome, consisting of 2,546 phosphorylation sites and 1,603 phosphoproteins, provides a roadmap to better understand the mechanisms that control differentiation in stem cells and a basis for continued research leading to potentially new clinical therapies.

The institute's California and Florida campuses will join the oncology chemical screening consortium.

The research partnership with Magellan is the first with a private company for Burnham's Lake Nona, Fla., branch, which in May opened its permanent location in the Orlando area after inhabiting temporary digs since 2006.

Maryland Biotechnology Investment Incentive Tax Credit, Maryland Stem Cell Research Fund, Washington State Life Sciences Discovery Fund, California Institute for Regenerative Medicine, Sanford Consortium for Regenerative Medicine, Missouri Life-Sci/Tech Tax Credits, Wisconsin Technology Venture Fund, New Jersey Edison Innovation Fund, University City Science Center QED

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.